CCM
TRML

Corsair Capital Management’s Tourmaline Bio TRML Stock Holding History

Corsair Capital Management’s Portfolio TRML Stock Details TRML Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-5,500
Closed -$167K – 117
2023
Q2 		$167K Buy
+5,500
New +$140K 0.06% 90

Other funds holding TRML

Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
QUSVM
Qiming U.S. Ventures Management Bellevue, Washington $55.6M AUM 98.09% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return

Corsair Capital Management's TRML Position: Q3 2023 in Review

Corsair Capital Management sold out of Tourmaline Bio (TRML) in Q3 2023, closing a stake of 5,500 shares — an estimated $167K sold.

Corsair Capital Management first reported a position in TRML in Q2 2023 and held it in 1 quarter. The position peaked at $167K in Q2 2023. 48 funds tracked by Wall St. Rank hold TRML as of Q3 2023.

  • Corsair Capital Management reported no remaining Tourmaline Bio position as of Q3 2023 after selling out during the quarter.
  • Corsair Capital Management sold 5,500 Tourmaline Bio shares in Q3 2023, an estimated $167K.
  • Corsair Capital Management first reported a position in Tourmaline Bio in Q2 2023 and held it in 1 quarter.
  • Corsair Capital Management's Tourmaline Bio position peaked at $167K in Q2 2023.
  • 48 funds tracked by Wall St. Rank held Tourmaline Bio as of Q3 2023.

Based on Corsair Capital Management's 13F filing for Q3 2023, filed 13 Nov 2023.